The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Electronic Drug Delivery Systems Market Projected To Expand During 2026–2030?
The electronic drug delivery systems market has experienced robust expansion in recent years. Its value is projected to increase from $11.93 billion in 2025 to $13.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. This past growth was driven by factors such as the increasing incidence of chronic diseases, the broadening scope of injectable and inhalable treatments, a rise in the application of infusion-based therapies, greater acceptance of home healthcare, and the presence of electronic drug delivery platforms.
The market for electronic drug delivery systems is anticipated to experience swift expansion in the upcoming years. This market is projected to reach $19.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. The expansion over the forecast period is largely driven by a rising demand for customized drug delivery, the increasing embrace of digital health ecosystems, the proliferation of remote patient monitoring, a heightened emphasis on outcomes influenced by adherence, and the greater incorporation of AI-based dosing algorithms. Key trends anticipated during this period encompass the growing acceptance of intelligent drug delivery devices, the increasing incorporation of interconnected and wearable delivery systems, the expanding utilization of precision dose control technologies, the wider availability of patient-focused self-administration devices, and a strengthened emphasis on tracking therapy adherence.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10734&type=smp
Which Growth Drivers Are Expected To Support The Electronic Drug Delivery Systems Market Forward?
The increasing incidence of chronic diseases is anticipated to drive the expansion of the electronic drug delivery systems market in the coming period. A chronic disease is characterized as a condition or ailment that persists for over a year and necessitates continuous medical care. Electronic drug delivery systems serve to manage drug doses and simplify the oversight of medication for individuals living with chronic diseases. For example, as reported in January 2023 by the National Library of Medicine, a US-based organization, the count of people in the US aged 50 and older suffering from at least one chronic condition is projected to rise to 142.66 million by 2050. This demonstrates that the escalating prevalence of chronic diseases will propel the electronic delivery system market.
How Are Different Segment Groups Identified Within The Electronic Drug Delivery Systems Market?
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors
Which Trends Are Contributing To Changes In The Electronic Drug Delivery Systems Market?
Key players in the electronic drug delivery systems market are prioritizing innovative solutions, such as reusable electronic injector platforms, to bolster drug delivery accuracy, patient compliance, and environmental responsibility. A reusable electronic injector platform is a smart, battery-powered injection tool designed for multiple uses to administer precise medication doses, while also tracking usage and supporting patient adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, introduced PRIME Nexus, a new reusable electronic injector platform developed to enhance the administration of injectable medications, featuring specific improvements for precision, versatility, and sustainability in drug delivery. It supports various drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can manage high-viscosity formulations up to 600 cP. The device offers programmable injection control and optional connectivity for monitoring adherence and sharing data with healthcare providers. Its reusable construction promotes sustainability by reducing medical waste and decreasing overall injection expenses.
Which Organizations Are Involved In The Electronic Drug Delivery Systems Market?
Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.
Access The Complete Electronic Drug Delivery Systems Market Report:
Which Region Has The Strongest Presence In The Electronic Drug Delivery Systems Market?
North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Electronic Drug Delivery Systems Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=10734&type=smp
Browse Through More Reports Similar to the Global Electronic Drug Delivery Systems Market 2026, By The Business Research Company
Electroencephalography Eeg And Electromyography Emg Equipment Market Report 2026
Electro Medical And Electrotherapeutic Apparatus Market Report 2026
Electrocardiography Ecg Electrodes Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model